Sanofi India Ltd SANOFI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- ₹6,795.40
- Day Range
- ₹6,673.90–6,800.00
- 52-Week Range
- ₹5,892.80–10,524.95
- Bid/Ask
- ₹6,784.35 / ₹6,780.00
- Market Cap
- ₹156.25 Bil
- Volume/Avg
- 12,127 / 20,196
Key Statistics
- Price/Earnings (Normalized)
- 34.59
- Price/Sales
- 5.56
- Dividend Yield (Trailing)
- 2.46%
- Dividend Yield (Forward)
- 2.46%
- Total Yield
- 2.46%
Company Profile
Sanofi India Ltd is a drug manufacturing company that focuses on a range of therapeutic areas, including Diabetes, Cardiology, Consumer Healthcare, Hospital, Central Nervous System, and Anti-Histamines. The company's diabetes presence includes oral anti-diabetic products and insulin. The consumer healthcare area also maintains a nutraceutical portfolio. The company's export markets include Germany, the U.K., Australia, and Russia. The company utilizes strategic partnerships as a component of its growth.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- Mid Core
- Total Number of Employees
- 2,174
- Website
- https://www.sanofiindialtd.com
Comparables
Valuation
|
Metric
|
SANOFI
|
532815
|
524348
|
|---|---|---|---|
Price/Earnings (Normalized) | 34.59 | 50.08 | 30.05 |
Price/Book Value | — | 5.63 | 3.65 |
Price/Sales | 5.56 | 3.88 | 1.95 |
Price/Cash Flow | — | 34.49 | 20.81 |
Price/Earnings
SANOFI
532815
524348
Financial Strength
|
Metric
|
SANOFI
|
532815
|
524348
|
|---|---|---|---|
Quick Ratio | 0.69 | 0.86 | 0.91 |
Current Ratio | 1.37 | 1.61 | 1.66 |
Interest Coverage | 392.21 | 4.55 | 7.34 |
Quick Ratio
SANOFI
532815
524348
Profitability
|
Metric
|
SANOFI
|
532815
|
524348
|
|---|---|---|---|
Return on Assets (Normalized) | 30.67% | — | — |
Return on Equity (Normalized) | 59.54% | — | — |
Return on Invested Capital (Normalized) | 52.43% | — | — |
Return on Assets
SANOFI
532815
524348
Drug Manufacturers - General Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Eli Lilly and Co
LLY
| Dxbgmrhg | Vwydp | $808.9 Bil | |||
| Johnson & Johnson
JNJ
| Vkjfcmslz | Sjdvv | $384.0 Bil | |||
| AbbVie Inc
ABBV
| Ztckrtmm | Yktns | $342.0 Bil | |||
| Merck & Co Inc
MRK
| Dnrmhznwl | Nsfdw | $275.3 Bil | |||
| Roche Holding AG ADR
RHHBY
| Hthbdzccs | Spttv | $243.9 Bil | |||
| AstraZeneca PLC ADR
AZN
| Fmtmwnslgj | Psvj | $240.3 Bil | |||
| Novartis AG ADR
NVS
| Hbmwyyc | Tbvwg | $230.4 Bil | |||
| Amgen Inc
AMGN
| Wypvhdskwt | Jhkq | $170.6 Bil | |||
| Pfizer Inc
PFE
| Nxhntwvz | Cstd | $165.5 Bil | |||
| Sanofi SA ADR
SNY
| Hbzndcw | Pxtr | $138.7 Bil |
United States